Improving the detection of pulmonary hypertension in systemic sclerosis using pulmonary function tests
- 28 October 2011
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 63 (11) , 3531-3539
Abstract
Objective: To construct a readily applicable formula for selecting patients with systemic sclerosis (SSc) for right‐sided heart catheterization (RHC) based on the results of their pulmonary function tests (PFTs).Methods: The diagnostic value of PFT variables was quantified in 386 patients with SSc against data obtained from RHC.Results: We derived the following formula using data from 257 patients: predicted mPAP = 136 – SpO2 – 0.25 × DLCO % predicted, where mPAP is the mean pulmonary artery pressure, SpO2 is the oxygen saturation as measured by pulse oximetry, and DLCO is the diffusing capacity for carbon monoxide. We validated the formula in the remaining 129 SSc patients. The area under the curve was 0.75 (95% confidence interval [95% CI] 0.67, 0.84). Using a predicted threshold of 25 mm Hg, the sensitivity was 90.1% (95% CI 82, 96) and the specificity was 29.2% (95% CI 17, 44). When used as a screening procedure in a typical scleroderma patient population, it is projected that those with an mPAP below 25 mm Hg are unlikely to have pulmonary hypertension (PH; prevalence 4.4%), those with a predicted mPAP of 25–35 mm Hg are at average risk of having PH (prevalence of 11.3%), and those with a formula‐predicted mPAP above 35 mm Hg are likely to have PH (prevalence of 62.9%), thus justifying RHC. In patients with equivocal findings on echocardiography, a high formula‐predicted mPAP is strongly associated with the presence of PH.Conclusion: We derived and validated an easily applied formula for determining pulmonary function in patients with SSc that identifies subgroups with a low, average, or high prevalence of PH. It provides information that is complementary to echocardiography and that should improve the selection of patients for RHC.Keywords
This publication has 18 references indexed in Scilit:
- Correlation of pulmonary function variables with hemodynamic measurements in patients with pulmonary arterial hypertensionThe Clinical Respiratory Journal, 2010
- Pulmonary hypertension with left-sided heart diseaseNature Reviews Cardiology, 2010
- Assessing Pulmonary Disease and Response to Therapy: Which Test?Seminars in Respiratory and Critical Care Medicine, 2010
- Improved survival in systemic sclerosis is associated with better ascertainment of internal organ disease: a retrospective cohort studyQJM: An International Journal of Medicine, 2009
- Guidelines for the diagnosis and treatment of pulmonary hypertensionEuropean Respiratory Journal, 2009
- Accuracy of Doppler Echocardiography in the Hemodynamic Assessment of Pulmonary HypertensionAmerican Journal of Respiratory and Critical Care Medicine, 2009
- Prediction of pulmonary hypertension in idiopathic pulmonary fibrosisRespiratory Medicine, 2007
- Pulmonary arterial hypertension in systemic sclerosis: the need for early detection and treatmentInternal Medicine Journal, 2007
- Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approachAnnals of the Rheumatic Diseases, 2003
- Fibrosing alveolitis in systemic sclerosis. Indices of lung function in relation to extent of disease on computed tomographyArthritis & Rheumatism, 1997